Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.

about

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

P2860

Q26797521-B73CAC09-54B1-4B2A-8A26-08D155AD0013

P2860

Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q44199365

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Prognostic performance of preo ...... able hepatocellular carcinoma.

@en

Prognostic performance of preo ...... able hepatocellular carcinoma.

@nl

type

Item

label

Prognostic performance of preo ...... able hepatocellular carcinoma.

@en

Prognostic performance of preo ...... able hepatocellular carcinoma.

@nl

prefLabel

Prognostic performance of preo ...... able hepatocellular carcinoma.

@en

Prognostic performance of preo ...... able hepatocellular carcinoma.

@nl

P1476

Prognostic performance of preo ...... able hepatocellular carcinoma.

@en

P2093

Han Chu Lee

http://www.w3.org/2001/XMLSchema#string

Kang Mo Kim

http://www.w3.org/2001/XMLSchema#string

Seungbong Han

http://www.w3.org/2001/XMLSchema#string

Sung-Gyu Lee

http://www.w3.org/2001/XMLSchema#string

Yong Moon Shin

http://www.w3.org/2001/XMLSchema#string

Young-Joo Lee

http://www.w3.org/2001/XMLSchema#string

Young-Suk Lim

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

Hepatoma--resection or transplantation.

Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.

Diagnostic accuracy of multi-/single-detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the milan criteria before liver transplantation.

Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatoce

Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.

Focal liver lesion detection and characterization with GD-EOB-DTPA.

P304

1115-1123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMRI.24660

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ju Hyun Shim

P577

2014-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24841479

http://www.w3.org/2001/XMLSchema#string

Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.

about

P2860

P2860

Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698